Double-blind Comparison of the Respiratory and Sedative Effects of Codeine Phosphate and (+/-)-glaucine Phosphate in Human Volunteers
Overview
Authors
Affiliations
1 Two antitussive agents (+/-)-glaucine phosphate and codeine phosphate have been compared with placebo with respect to ventilation, ventilatory response to carbon dioxide, pulse, blood pressure, digit symbol substitution, sedation score and the Zahlen-Verbindung test performance in ten healthy volunteers (22-36 years). The study was double-blind and the two doses of each antitussive agent and the placebo were administered as a syrup. 2 Both codeine phosphate and (+/-)-glaucine phosphate displaced the ventilatory response to carbon dioxide to the right. 3 The effect of codeine phosphate on the ventilatory response to carbon dioxide was not dose dependent: 30 mg produced greater effects than the 60 mg dose. 4 Only the highest dose of (+/-)-glaucine phosphate (60 mg) caused respiratory depression and this was associated with sedation and decreased performance in the digit symbol substitution test. 5 Neither antitussive agent had significant effects upon pulse or blood pressure and codeine phosphate had no detectable sedative activity.
Sun T, Wu Z, Wang X, Wang Y, Hu X, Qin W Oncogene. 2020; 39(31):5358-5372.
PMID: 32576970 DOI: 10.1038/s41388-020-1338-9.
The role of the opioid system in decision making and cognitive control: A review.
van Steenbergen H, Eikemo M, Leknes S Cogn Affect Behav Neurosci. 2019; 19(3):435-458.
PMID: 30963411 PMC: 6599188. DOI: 10.3758/s13415-019-00710-6.
Antitussive drugs--past, present, and future.
Dicpinigaitis P, Morice A, Birring S, McGarvey L, Smith J, Canning B Pharmacol Rev. 2014; 66(2):468-512.
PMID: 24671376 PMC: 11060423. DOI: 10.1124/pr.111.005116.
Codeine and clinical impairment in samples in which morphine is not detected.
Bachs L, Skurtveit S, Morland J Eur J Clin Pharmacol. 2003; 58(12):785-9.
PMID: 12698303 DOI: 10.1007/s00228-003-0561-y.
Objective evaluation of dextromethorphan and glaucine as antitussive agents.
Ruhle K, CRISCUOLO D, Dieterich H, Kohler D, Riedel G Br J Clin Pharmacol. 1984; 17(5):521-4.
PMID: 6375709 PMC: 1463443. DOI: 10.1111/j.1365-2125.1984.tb02384.x.